Table 1.
Control | APE | AND | |
---|---|---|---|
Body weight (g) | |||
Initial | 271 ± 16 | 272 ± 7 | 272 ± 8 |
Final | 337 ± 10a | 307 ± 12b | 332 ± 13a |
Liver weight (g) | 14.4 ± 1.2 | 13.3 ± 0.7 | 12.8 ± 1.5 |
Relative liver weight (%) | 4.3 ± 0.4 | 4.3 ± 0.4 | 3.8 ± 0.3 |
Plasma aminotransferases (U/L) | |||
AST | 24.8 ± 5.4 | 23.5 ± 5.7 | 27.7 ± 4.4 |
ALT | 14.7 ± 2.4 | 12.9 ± 2.2 | 15.8 ± 8.2 |
Rats were orally dosed daily with 2 g/kg of APE or 50 mg/kg of AND for 5 days. Relative liver weight = (liver weight/ body weight) × 100. AST: aspartate aminotransferase; ALT: alanine aminotransferase. The values represent the mean ± SD, n = 5. The significance of the difference among group means was determined by one-way ANOVA followed by Tukey's test. abValues of treatments not sharing the same letter differ significantly, P < 0.05.